FIT screening

Colorectal cancer (CRC) is one of the most frequently diagnosed cancers. The good news is that CRC incidence and mortality can be reduced significantly if detected early enough.

Faecal immunochemical tests (FIT) are non-invasive and can detect blood in stool invisible to the naked eye. Due to its simplicity, FIT is currently considered the best non-invasive test for CRC screening.

Invest a little time in your own health by taking the FIT to prevent or detect colon cancer early on.
For further information, please visit our ‘FIT for screening’ website www.fitscreening.eu/patients

Investors

Our holding company, Sysmex Corporation, is listed on the Tokyo stock exchange. For the latest financial information, please visit our investor relations page on our holding company website.

Investor information

The Sysmex Way

Mission, value and mind come together to form the way we work, think and act.

Discover Our Way
Enjoy our Media Centre
All
  • All
  • Documents
  • Podcast
  • Images
  • Videos
SUSPECTED HUS IN ROUTINE ANALYSIS
See the Podcast
See our collection